AI and rare disease: with great power comes great responsibility!

Monday 4 March 2024
12:00 - 13:30 (GMT)

Artificial Intelligence (AI) is fast becoming a universal theme in healthcare’s (r)evolution, offering the potential to improve diagnoses and tailor treatments. These advantages can be particularly important in rare diseases. However, the use of AI in rare diseases raises several questions about data security, equity, diversity, and responsibility, which have yet to be fully answered.

Join our upcoming online session to delve into AI’s transformative role in the evolution of healthcare.

Following on from our marking of Rare Disease Day on Thursday 29 February 2024, join us online to continue the discussion with this bite-sized educational session. Led by innovators in this field, the session will provide an opportunity to equip and inform interested learners about the foundation for the challenges posed and how they might be applicable in pharmaceutical medicine now and in the future.

What you will learn

  • Responsible research in artificial intelligence
  • Learnings from a pilot program
  • The challenges ahead


Prof Elvira Perez-Vallejos
Responsible research in artificial intelligence

Laura MacDonald and Mark Goodyear (Carecircle Technology Ltd)

Rare Diseases Implementation Group Coordinator
Learnings from a pilot program

Dr Tony Lockett
Chair of the FPM Rare Disease Expert Group and Senior Lecturer, King’s College London
The challenges ahead

Find out more about our speakers

Elvira Perez-Vallejos

Elvira, Professor of Mental Health and Technology at School of Medicine and School of Computer Science (50/50 appointment) at the University of Nottingham (UoN) Elvira’s research portfolio (>£80M) is highly interdisciplinary with funding from UKRI (AHRC EPSRC, MRC) and NIHR. She specialises in assessing the impact that technology has on the mental wellbeing of groups with protected characteristics (children, young people, older adults) applying co-design and participatory methods (e.g., Youth Juries). She is driving world-leading research on digital mental health including issues of data ethics and privacy, user and stakeholder engagement, co-production, and responsible innovation.


This event will take place online on:

Monday 4 March 2024 12:00-13:30 (GMT)

Price options:

FPM Members £40

Non-Members £60

Reduced rate* £20

*Reduced rates are available for FPM members who fulfil one of the following criteria: PMST trainees, people from low and lower-middle income countries, unemployed, part-time employed (earning less than £15,000 per year), people on Parental Leave, people who are Out of Practice & Retired, those who work for a charity.

Booking closes at 12:00pm the day before the event date.
Please see our booking terms and conditions and our privacy policy

CPD Credits

You can find instructions and guidance regarding CPD eligibility here.

Approve for CPD

Booking Information

Joining instructions will be emailed to registered attendees periodically, with a final reminder email sent one hour (online events) prior to the event. Please don’t forget to check your junk folder!

Queries: If you are unable to complete your booking online or have any questions, please email 

Secure your spot now

You may also be interested in:

DPM Training Programme 2024 | Module 1: Regulatory Affairs

Find out more

AI and rare disease: with great power comes great responsibility!

Find out more

DPM Training

DPM Training Programme 2024 | Book All Modules

Find out more

Fireside Chat with Dr Emma Harvey

Find out more

FPM Examiner Training Day

Find out more

DPM Training Programme 2024 | Module 2: Statistics and Data Management

Find out more

The views, information, or opinions expressed during FPM events and training are those of the individuals involved and do not necessarily represent those of the Faculty of Pharmaceutical Medicine. We value inclusivity, equality and diversity, and work hard to promote these whenever possible in all of our activities. We welcome your comments and feedback: